SCHEMBL30438744

SCHEMBL30438744

CCC1CNCCCN1S(=O)(=O)c1cc2ccccc2c(OC)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 2/20 0.38
▸ MMP9 P14780 2/20 0.38
▸ MMP13 P45452 2/20 0.38
▸ ROCK2 O75116 4/20 0.37
▸ ROCK1 Q13464 4/20 0.37
▸ PRKACA P17612 4/20 0.37
▸ PRKCD Q05655 4/20 0.37
▸ PRKD3 O94806 3/20 0.37
▸ PRKCZ Q05513 3/20 0.37
▸ PRKACG P22612 3/20 0.37
▸ PRKACB P22694 3/20 0.37
▸ PLK4 O00444 2/20 0.37
▸ MARK3 P27448 2/20 0.37
▸ PRKAA1 Q13131 2/20 0.37
▸ PKN2 Q16513 2/20 0.37
▸ MARK2 Q7KZI7 2/20 0.37
▸ AURKB Q96GD4 2/20 0.37
▸ PRKD2 Q9BZL6 2/20 0.37
▸ AURKA O14965 1/20 0.37
▸ DCLK1 O15075 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439034 0.88 MMP1 (0.35) MMP1MMP9MMP13ROCK2ROCK1
SCHEMBL23795370 0.78 ROCK1 (0.45) ROCK2ROCK1PRKACAPRKCDPRKD3
SCHEMBL30439073 0.78 ROCK1 (0.45) ROCK2ROCK1PRKACAPRKCDPRKD3
SCHEMBL30439464 0.78 ROCK1 (0.45) ROCK2ROCK1PRKACAPRKCDPRKD3
SCHEMBL23795372 0.78 ROCK1 (0.45) ROCK2ROCK1PRKACAPRKCDPRKD3
SCHEMBL30439065 0.78 TAAR1 (0.43) MMP1MMP9MMP13ROCK2ROCK1
SCHEMBL30439166 0.78 MMP1 (0.47) MMP1MMP9MMP13HTR6
SCHEMBL30439345 0.73 ROCK2 (0.51) MMP1MMP9MMP13ROCK2ROCK1
SCHEMBL30438733 0.73 ROCK2 (0.38) MMP1MMP9MMP13ROCK2ROCK1
SCHEMBL23795312 0.70 ROCK1 (0.42) ROCK2ROCK1PRKACAPRKCDPRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback